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Abstract  
Background 
Recent clinical practice guidelines have highlighted the importance of advance care planning 
(ACP) for improving end-of-life care for people with chronic kidney disease (CKD). 
Study Design 
We conducted a systematic integrative review of the literature to inform future ACP practice 
and research in CKD, searching electronic databases in April 2013. Synthesis used narrative 
methods.  
Setting & Population 
We focused on adults with a primary diagnosis of CKD in any setting. 
Selection Criteria for Studies 
We included studies of any design, quantitative or qualitative..  
Interventions 
ACP was defined as any formal means taken to ensure health professionals and family 
members are aware of patients’ wishes for care in the event they become too unwell to speak 
for themselves. 
Outcomes 
Measures of all kinds were considered to be of interest.  
Results 
Fifty-five articles met criteria reporting on 51 discrete samples. All patient samples included 
people with Stage 5 CKD; two also included patients with Stage 4. Seven interventions were 
tested; all were narrowly focused and none was evaluated by comparing wishes for end-of-
life care with care received. One intervention demonstrated effects on patient/family 
outcomes in the form of improved wellbeing and anxiety following sessions with a peer 
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mentor. Insights from qualitative studies that have not been emphasised in interventions 
include the importance of instilling patient confidence that their advance directives will be 
enacted and discussing decisions about (dis)continuing dialysis separately from ‘aggressive’ 
life-sustaining treatments (e.g. ventilation). 
Limitations 
Whilst quantitative and qualitative findings were integrated according to best practice, 
methods for this are in their infancy. 
Conclusions 
Research on ACP in patients with CKD is limited, especially regarding intervention studies. 
Interventions in CKD should attend to barriers and facilitators at the levels of patient, 
caregiver, health professional and system. Intervention studies should measure impact on 
compliance with patient wishes for end-of-life care. 
Index words 
Chronic kidney disease, Renal failure, Advance care planning, Advance directives, Decision-
making 
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Manuscript 
Background   
Chronic kidney disease (CKD) is a significant health problem internationally. Despite 
technological improvements, annual mortality rates for patients on dialysis are consistently 
high - 10% to 25% in both developed and emerging nations1. For older patients with multiple 
comorbidities, dialysis may not improve survival and may be detrimental to quality of life 
(QOL)2. The importance of supportive care for patients with end-stage kidney disease 
(ESKD) is increasingly recognized both for patients receiving dialysis and those who choose 
not to commence or to withdraw from dialysis3,4.  
Cognitive impairment is common in patients receiving long-term dialysis4,5, leaving families 
and nephrologists to decide whether and when to withdraw dialysis after patients have lost 
capacity to decide for themselves. The emotional burden of family decision-making, and the 
poor concordance between surrogate decisions and patient preferences6, raises concerns that 
some patients may remain on dialysis for longer than they would have chosen. Some ESKD 
patients may also receive life-sustaining treatments (e.g. cardiopulmonary resuscitation 
[CPR], ventilation) that they would not have wanted if they could have chosen3. 
Advance care planning (ACP) refers to a process of reflection, and discussion between a 
patient, their family and healthcare providers for the purpose of clarifying values, treatment 
preferences and goals of end-of-life (EOL) care7. ACP provides a formal means of ensuring 
healthcare providers and family members are aware of patients’ wishes for care if they 
become unable to speak for themselves8,9. ACP is a patient-centred initiative that promotes 
shared decision-making, which may include the patient completing an advance directive 
(AD) that documents their wishes and/or the appointment of a substitute decision-maker.  
In general medical settings, ACP has been shown to increase patient and family satisfaction 
with care10,11 and the likelihood that doctors and family members will understand and comply 
with patients’ wishes for EOL care10,12-14.  It also increases the likelihood of a person dying in 
their preferred place, increases hospice use14,15, reduces hospitalisation11,15, leads to less 
‘aggressive’ medical care at EOL14,16,17, and contributes to lower stress, anxiety and 
depression in surviving relatives10,11,13,14.  
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The importance of ACP for people with CKD has been highlighted in recent literature and 
clinical practice guidelines, especially during the later stages9,18-26. We undertook a 
systematic integrative review of ACP in CKD in order to:  
1. Identify what interventions have been developed, piloted and evaluated;  
2. Identify which measures have been used in intervention and other studies ; 
3. Establish evidence for the efficacy of interventions; 
4. Inform understanding of barriers and facilitators to implementation as well as 
stakeholders’ perceptions of ideal approaches. 
Methods   
Eligibility criteria 
We included articles published in peer-reviewed, English-language journals, reporting 
original research. Samples had to be adults with a primary diagnosis of CKD and/or families 
and the health professionals caring for this group. We excluded studies on children and 
adolescents because of the different implications for shared decision-making with families. 
Where samples included patients with other primary diagnoses, studies were included if 
>50% of the study group had CKD or where results for this sub-group were provided 
separately. Articles were excluded where it was not possible to determine what percentage of 
the study group had CKD. Because studies of any design have potential to inform clinical 
practice, we took an integrative approach that included research with qualitative, quantitative 
or mixed methods27. Qualitative studies were defined as those attempting to make sense of 
phenomena in terms of the meanings people bring to them28. We limited our search to peer-
reviewed literature to ensure a minimum standard among methods of included studies. To 
further control quality, we excluded published conference abstracts and case studies and 
required articles reporting qualitative studies to provide an aim and at least one sample of raw 
data (e.g. verbatim patient statements). . Recent evidence suggests that limiting to English is 
unlikely to result in systematic bias29. 
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Information sources 
The electronic databases Medline, PsycINFO, Embase, AMED, CINAHL and Sociological 
Abstracts were searched from their earliest records until 29th April 2013.  We also hand 
searched the reference lists of included articles. 
Searches 
The search strategy made use of medical subject headings (MeSH) or equivalent and 
keywords relating to CKD and ACP. Search terms for ACP were those developed by the 
Australian Palliative Care Knowledge Network, CareSearch30. See Box 1 (supplementary 
material) for an example. 
Study selection 
Inclusion/exclusion was undertaken by a single reviewer after dual coding of 100 articles 
found agreement to be 99%.  
Data collection and items 
Data were extracted by one of two reviewers using an electronic (Microsoft Excel 2010) 
proforma specifying data items. Data items included study type (quantitative, qualitative, 
mixed methods), country of origin, aims, research questions, setting, sample characteristics 
and findings; for qualitative articles only: conceptual approach (e.g. grounded theory) and 
method of data collection (e.g. interviews); and for quantitative studies only: design 
(descriptive, analytic, intervention), whether cross-sectional or longitudinal, and outcomes. 
Data items for interventions included their focus/purpose, theoretical derivation, delivery, 
intensity, and any information available about training and feasibility (e.g. adherence). 
Risk of bias 
Integrative reviews require multiple tools to assess study quality. Risk of bias was assessed 
only for intervention studies according to criteria published by the Agency for Healthcare 
Research and Quality (AHRQ) US Preventive Services Task Force 31 where an overall rating 
of “good’, “fair” or “poor’ is allocated to each study (see Table 1). Each study was rated 
independently by two reviewers who then met to reach consensus. 
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Table 1 about here 
Synthesis   
With the exception of testing intervention efficacy (Objective 3), which used meta-analysis, 
synthesis took a narrative approach using techniques described by Popay and colleagues, 
namely: tabulation, textual descriptions, grouping and clustering, transformation of data to 
construct a common rubric, vote counting, and translation of data through thematic and 
content analysis32-34. 
Objective 2 – Description of ACP-related measures 
Extracted information regarding measures was tabulated to indicate frequency and range, and 
the existence, or otherwise, of a standard set.  
Objective 3 – Efficacy of ACP 
The efficacy of ACP interventions was synthesised by meta-analysis where studies met 
criteria described in the Cochrane Handbook of Systematic Reviews35. Meta-analysis was 
conducted using Review Manager 5 software and a random effects model to control for 
heterogeneity among samples and methods. Where studies did not meet criteria for meta-
analysis, a narrative approach to synthesis was undertaken32-34. 
Objective 4 – Barriers and facilitators and stakeholder’s perceptions of ideal ACP  
Analysis of barriers and facilitators used the ‘multilevel’ approach36 recommended by the 
Cochrane Handbook of Systematic Reviews37, where qualitative and quantitative evidence is 
compared, guided by three questions: 
1. Which interventions match recommendations derived from patient/family/health 
professional views and experiences? 
2. Which recommendations have yet to be tried in soundly evaluated interventions? 
3. Have those interventions that match recommendations demonstrated higher efficacy 
(and, in the case of meta-analyses, does following, versus not following, these 
recommendations explain heterogeneity)? 
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Comparative analyses were summarised in matrices identifying the number of good quality 
and other intervention studies that met each recommendation. This was intended to give a 
clear indication of gaps in the literature and further inform understanding of efficacy. 
Recommendations used to populate the matrix were generated via thematic synthesis32-34. 
Synthesis focused on information relevant to ACP only. Themes were independently 
generated by two reviewers who then met to reach consensus. 
Results 
Study selection  
Of 2,764 results returned by database searches, 42 articles met inclusion criteria. A further 13 
relevant articles were identified via hand searching, providing a total of 55 articles reporting 
on studies with 51 discrete samples38-93. See Figure 1 for a summary of inclusion/exclusion. 
Figure 1 about here 
Study characteristics  
A summary of study characteristics is presented in Table 2. All patient samples included 
people with Stage 5 CKD (also described as end stage kidney disease; ESKD), and two Stage 
4 CKD.  
Table 2 about here 
More detailed information about the design, samples and interventions reported in 
intervention, descriptive and qualitative studies is provided in Supplementary Tables S1, S2 
and S3 respectively.  
Risk of bias within studies  
Of eight intervention studies identified, four were randomised controlled trials 
(RCTs)60,73,75,89, two used a pre/post design54,92 and two reported post data without 
comparison54,77. Rating of bias identified six of these studies as poor quality54,60,73,77,92 and 
two as fair75,89; both fair quality studies used randomised allocation. Studies rated poor either 
omitted to control for drop-out and confounders or included no statistical analyses.  
Synthesis of results  
Objective 1 – Description of ACP interventions 
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Altogether, seven ACP interventions were evaluated in eight studies54,60,73,75,77,89,92. One 
article reported on two interventions evaluated in separate studies54, while another 
intervention was assessed at both pilot and evaluative phases by Song and colleagues (2009, 
2010)73,75. Details of the interventions are provided in Supplementary Table S4. 
Interventions aimed to: educate nurses about discussing EOL care54, facilitate documentation 
of preferences for EOL care in ADs60,77,89, enhance communication between patients and 
their surrogate decision-makers about EOL care and preferences73,75, introduce the topic of 
ADs to patients and assist them in expressing their resuscitation preferences77, or deliver ACP 
as a component of a larger palliative care intervention92.  
Only the intervention assessed by Song et al was explicitly theory-based73,75, namely a 
representational approach based on models of ‘common sense’ and ‘conceptual change’94. 
Both studies evaluated a 1-hour ACP education and interview session administered by nurse 
facilitators. The only difference in the intervention between pilot and evaluative phases was 
the intensiveness with which facilitators were trained (2.573 versus 3.575 days). 
Three of the interventions were delivered by health care providers54,73,75,92, one by trained 
patient mentors60, two via printed materials77,89, and two via video (one for nurses, the other 
for peer facilitators)54,60. The interventions delivered by healthcare providers were a single 
education and interview session73,75, an education program over an undefined number of 
sessions54, and a needs-based palliative care consultation92. The peer-mentor ACP 
intervention was administered over five telephone calls and three face-to-face meetings with 
support from video60, while interventions delivered via printed materials77,89 and video for 
nurses were administered as one-off only54.      
Objective 2 – Description of ACP-related measures 
In 45 quantitative studies, 110 measures were used, most commonly relating to patient and/or 
family preferences, attitudes and knowledge, and AD completion rates (see Table 3). Articles 
also commonly reported analyses examining socio-demographic and clinical variables 
predicting these measures. . Five of the eight intervention studies measured intervention 
acceptability54,77,89,92. No studies assessed compliance with patient wishes at EOL, family 
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members’ satisfaction with the patients’ EOL care, nor the effect on the well-being of 
bereaved family members. 
Table 3 about here 
Objective 3 – Efficacy of ACP 
Patient or family well-being, anxiety, or quality of life: Only the studies by Song and 
colleagues (2009, 2010)73,75 met criteria for meta-analysis stipulated by the Cochrane 
Handbook of Systematic Reviews35, and two was considered too small a number for meta-
analysis to be conducted. Neither study found a significant effect on wellbeing for either 
patients or surrogates.  
Only the study by Perry et al (2005) found a significant effect on any of these outcomes, with 
African-Americans participating in peer-mentor facilitated ACP sessions showing greater 
improvement on subjective wellbeing and anxiety compared to their usual care 
counterparts60. 
Weisbord et al (2003) found no significant effect on symptoms or QOL from a palliative care 
intervention that included ACP alongside symptom management92. 
Patient/surrogate decisional conflict, confidence and congruence: The two studies by Song 
and colleagues (2009, 2010) measured all these outcomes73,75. Neither study found a 
significant effect for decisional conflict. In both studies, Song found an effect for 
concordance between patient wishes and surrogate knowledge of those wishes over time. In 
the 2009 study, there was also a rise in surrogate confidence in decision-making compared to 
baseline.  
Tigert et al (2005) found that 70% of patients were prepared to state their CPR preferences 
after reading a pamphlet used to introduce the topic of ADs to ESKD patients and their 
surrogate decision-makers77. 
Patient-clinician communication and interaction: The two Song et al studies found a 
significant effect on both patient-clinician communication  and interaction73,75.  
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Health provider ACP competence and confidence: Following “several” teaching sessions, 
Hopkins et al (2011) reported moderate improvement in nurses’ self-reported knowledge 
about refusal to initiate dialysis, confidence in initiating EOL discussions with patients and 
familiarity with EOL resources; however, there was no control group54. The same authors 
also reported improvements from an educational video describing methods to engage in EOL 
care planning, with 44% of nurse participants reporting greater confidence in initiating and 
pursuing EOL discussions after watching the video.  
Completion of advance directives: Three studies examined how ACP interventions influenced 
documentation completion by patient and surrogate60,89,92. Only the peer-mentor-facilitated 
ACP sessions tested by Perry et al (2005) increased AD completion compared to usual care; 
AD completion rates were also significantly higher than for ACP materials presented without 
facilitation60. 
Acceptability of ACP interventions: Results for acceptability of ACP interventions varied 
across different interventions and measures54,77,89,92, but were generally positive. Sixty eight 
percent of patients and 76% of nephrologists rated the palliative care intervention 
worthwhile92,70%  of patients found an AD pamphlet helpful77, and 93% of nurses found an 
educational video somewhat or very useful54. Acceptability for three alternative ADs 
evaluated by Singer et al (1995) varied between 60% and 70%89. 
Objective 4 – Barriers and facilitators and stakeholder’s perceptions of ideal ACP  
Findings in six qualitative studies informed how to do ACP in adults with CKD40,41,45,48,55,72. 
See Table 4 for a matrix of recommendations developed via synthesis of results from these 
studies and cross-tabulation with the intervention studies. 
Table 4 about here 
Discussion 
This is the first systematic review to focus exclusively on studies concerned with ACP in 
CKD. It shows that studies to date have been mostly descriptive, exploring patient and family 
preferences and attitudes towards ACP and medical interventions at the EOL. The focal 
nature of decisions surrounding withdrawal of dialysis suggests a disease-specific approach 
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to ACP is warranted for people with CKD. A diversity of approaches and measures and 
paucity of controlled studies, however, mean that it is not yet possible to draw conclusions 
about the most effective ways to conduct ACP for patients in this group.  
The few interventions trialled to date have each focused on a single aspect of ACP such as 
nurse education, patient information, AD completion or patient/surrogate congruence. No 
intervention that met our inclusion criteria took a comprehensive approach to ACP that 
included attention to patient, caregiver, health professional and system related factors. A 
“whole system” approach to ACP has been shown to be effective in improving outcomes for 
patients and their surviving relatives in other settings10, and may be similarly beneficial for 
renal patients. A study reported by Kirchoff and colleagues (2010, 2012) examined the effect 
of a comprehensive ACP intervention but could not be included because patients with CKD 
constituted only a minority (42%) of the sample, which was predominantly made up of 
patients with congestive heart failure 95,96. 
The second weakness identified by this systematic review is that intervention studies have 
used only a limited variety of measures. No study measured compliance with patient wishes 
for EOL care , arguably the most important outcome of ACP. The study by Kirchoff and 
colleagues found a non-significant trend towards influencing this outcome but was not 
appropriately powered96. Complex interventions like ACP also benefit from measurement 
models that link processes to outcomes so that mechanisms of effect can be understood and 
replicated or adapted in future 97. This approach was lacking in the intervention studies we 
found. 
Only one ACP intervention has demonstrated effects on patient or family outcomes, namely 
improved subjective wellbeing and reduced anxiety following repeated peer mentor 
facilitated sessions60. This and three other interventions have demonstrated impacts on 
process measures, including patient-clinician interaction and communication73,75, patient-
surrogate congruence in EOL care preferences73,75, surrogate confidence75, nurse 
confidence54, and completion of ADs60. Whilst the latter was the most commonly used 
measure in the studies reviewed, it is important to note that completion of ADs in isolation 
may not always influence care received at the EOL98. Evidence for effects on nurse 
confidence is limited by poor study design and the absence of statistical analysis60. Results on 
intervention acceptability are difficult to interpret because each study used a different 
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measure, and only one has provided comparative data54,77,89,92. None of the intervention 
studies looked at the effect of ACP on outcomes for bereaved family members.  
In line with findings from other patient populations99, this review found evidence for poor 
congruence between surrogate decision maker and patient preferences concerning EOL care 
decisions such as discontinuation of dialysis49,56,64,84. Descriptive studies show that surrogates 
are influenced by a combination of factors external to their perception of patient preferences 
or best interests when making medical treatment decisions, such as their own treatment 
preferences and perceptions of what most people would choose in the same 
circumstances56,64. The nurse-facilitated ACP intervention studied by Song et al. (2010) 
improved concordance between patient wishes and surrogate knowledge of those wishes, but 
the intervention group still showed a strong preference for life-sustaining treatments at the 
EOL 73. It should be noted that this intervention was focused on African-Americans who tend 
to show stronger preferences for life-sustaining treatments at the EOL compared to other 
groups 100. More studies are needed that link concordance with measures of how decisions are 
informed by knowledge of EOL interventions across different patient populations. 
Surprisingly, there are no studies examining ACP for CKD patients who are considering or 
have chosen a conservative/non-dialytic approach to care101. This is despite an emphasis in 
clinical practice guidelines that ACP should be available to all patients with CKD26. This gap 
has been acknowledged by the US Kidney End-of-Life Coalition which provides online 
information for patients and health professionals on ACP and palliative care, including 
resources on choosing not to start or withdraw from dialysis102. 
Future ACP interventions are especially encouraged to incorporate the following strategies 
recommended by qualitative research: acknowledgement of the role that family can play, 
both positively and negatively, in ACP; reassurance to patients that their EOL wishes will be 
respected as a motivator for undertaking ACP; and distinguishing between decisions about 
dialysis withdrawal from choices about other life-sustaining treatments such as CPR and 
ventilation. The latter is particularly of interest because of results from a descriptive study 
suggesting that withdrawal from dialysis may be discussed less often than decisions about 
CPR and ventilation50, emphasising the need for a CKD-specific approach to ACP. 
Qualitative studies have further highlighted the following important considerations for ACP 
in CKD: the individuality of preferences for ACP and EOL care, the optimal timing for the 
ACP intervention (balancing the imperative to raise ACP early because of risk of cognitive 
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decline with sensitivity to patient and family readiness), respecting patients’ wishes not to 
discuss the topic if they prefer. One study found that less than 10% of CKD patients had 
discussed EOL care with health professionals, suggesting that more patients need to be given 
this opportunity46. A qualitative study found that ESKD patients tended to wait for health 
professionals to raise ACP rather than raise it themselves48, while another found that 
nephrologists discussed EOL issues based on prognosis but struggled to identify a suitable 
juncture103. Without appropriately sensitive communication about prognosis, patients on 
dialysis may dramatically over-estimate their life expectancy104. A further study found that 
nurses felt uncomfortable raising ACP for fear of upsetting patients, eliciting anger from 
families, and being denigrated by senior staff 61. More research is needed on identifying and 
implementing facilitators to ACP at a systems level in nephrology clinics, to educate staff on 
the benefits of early ACP, and ensuring that staff have authorisation and time for ACP as 
‘core business’26. Assuming it can be validated, the tool for measuring readiness to discuss 
ACP in patients with CKD reported by Calvin and Eriksen (2006) may also be useful for both 
clinical and research purposes42. 
Limitations 
Our findings are limited by the number and quality of studies identified. Meta-analysis was 
not possible, requiring us to take a narrative approach to synthesis of quantitative studies. Our 
results are also limited by the methods of the review. Data were extracted by only one author 
via an electronic proforma intended to limit bias. Review processes requiring subjective 
judgement to be made (e.g. quality rating) was carried out by two researchers working 
independently. Whilst we followed best-practice recommendations for integrating 
quantitative and qualitative findings37, approaches to mixed methods remain in their infancy 
both in primary studies and reviews. Finally, a lack of detailed descriptions of interventions 
and process and outcome measures prevented more detailed analysis105. 
In conclusion, the current review found that most research on ACP in CKD to date has been 
descriptive and has focused on people who have chosen to pursue dialysis rather than 
conservative management.  
Unlike ACP interventions found successful in other patient groups, interventions in CKD 
have not paid attention to barriers and facilitators at the levels of patient, caregiver, health 
professional and system. Future intervention studies should measure impact on compliance 
with patient wishes for end-of-life care.  
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Figure legends 
Figure 1. Flowchart of review selection process 
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Box S1. Search strategy used for searching Medline 
Set#: Search terms 
1 exp Kidney Failure, Chronic/ 
2 Renal Insufficiency, Chronic/ 
3 (CRF or CKF or CRD or CKD).tw. 
4 ((chronic adj 3 renal) or (chronic adj3 kidney)).tw. 
5 Kidney Diseases/ 
6 Renal Insufficiency/ 
7 Renal Dialysis/ 
8 dialysis.tw. 
9 (pre-dialysis or "pre dialysis" or predialysis).tw. 
10 (hemodialysis or haemodialysis).tw. 
11 Or/1-10 
12 (chronic or end-stage or "end stage" or endstage).tw. 
13 11 and 12 
14 exp Advance Care Planning/ 
15 (advance* adj3 plan*).tw. 
16 exp Advance Directives/ 
17 Communication/ 
18 Physician-Patient Relations/ 
19 Professional-Patient Relations/ 
20 Caregivers/px 
21 exp Family/px 
22 Decision Making/ 
23 Choice Behaviour/ 
26 
 
24 Problem Solving/ 
25 Advance Directive Adherence/ 
26 "Outcome and Process Assessment (Health Care)"/ 
27 "Outcome Assessment (Health Care)"/ 
28 "Process Assessment (Health Care)"/ 
29 ((assess* adj3 outcome*) or (outcome* adj3 evaluat*)).tw. 
30 Or/14-16 or 17-29 
31 13 and 30 
32 limit 31 to english language 
33 
limit 32 to (addresses or autobiography or bibliography or biography or comment 
or dictionary or directory or editorial or in vitro or interactive tutorial or lectures or 
letter or news or newspaper article or patient education handout or periodical index 
or portraits or video-audio media or webcasts) 
34 32 not 33 
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Table 1. Criteria specified for ratings of good, fair and poor quality for randomised 
controlled trials and cohort studies by the Agency for Healthcare Research and Quality 
(AHRQ)  US Preventive Services Task Force Procedure manual 31* 
Criteria: 
 
•Initial assembly of comparable groups:  
◦For RCTs: adequate randomization, including first concealment and whether 
potential confounders were distributed equally among groups. 
◦For cohort studies: consideration of potential confounders with either 
restriction or measurement for adjustment in the analysis; consideration of 
inception cohorts. 
•Maintenance of comparable groups (includes attrition, cross-overs, adherence, 
contamination). 
•Important differential loss to follow-up or overall high loss to follow-up. 
•Measurements: equal, reliable, and valid (includes masking of outcome 
assessment). 
•Clear definition of interventions. 
•All important outcomes considered. 
•Analysis: adjustment for potential confounders for cohort studies, or intention to 
treat analysis for RCTs. 
Good: Meets all criteria: Comparable groups are assembled initially and maintained 
throughout the study (follow-up at least 80 percent); reliable and valid 
measurement instruments are used and applied equally to the groups; 
interventions are spelled out clearly; all important outcomes are considered; and 
appropriate attention to confounders in analysis. In addition, for RCTs, intention 
to treat analysis is used. 
Fair: Studies will be graded "fair" if any or all of the following problems occur, 
without the fatal flaws noted in the "poor" category below: Generally comparable 
groups are assembled initially but some question remains whether some (although 
not major) differences occurred with follow-up; measurement instruments are 
acceptable (although not the best) and generally applied equally; some but not all 
important outcomes are considered; and some but not all potential confounders 
are accounted for. Intention to treat analysis is done for RCTs. 
Poor: Studies will be graded "poor" if any of the following fatal flaws exists: Groups 
assembled initially are not close to being comparable or maintained throughout 
the study; unreliable or invalid measurement instruments are used or not applied 
at all equally among groups (including not masking outcome assessment); and 
key confounders are given little or no attention. For RCTs, intention to treat 
analysis is lacking. 
* Available online at 
http://www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual.pdf  
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Table 2. Summary of 51 studies* on advance care planning in  chronic kidney disease 
identified through systematic searches 
Characteristic   N   (%) 
Country  USA  35 (69) 
 Other  16 (31) 
Type Quantitative**   
  Intervention 8 (15) 
  Descriptive 40 (74) 
 Qualitative  6 (11) 
Sample*** Patient   
  Stage 5 CKD (ESKD) 42 (82) 
  Mixed Stage 4/5 CKD 2 (18) 
 Family/caregiver  6 (10) 
 Provider  11 (18) 
Setting Inpatient  5 (10) 
 Outpatient  24 (47) 
 Various  22 (43) 
ACP intervention Format Training 4 (50) 
  Information 2 (25) 
  Advance directive 2 (25) 
 Delivery 1:1 4 (44) 
  Group 1 (11) 
  Materials only 4 (44) 
ACP = advance care planning; CKD = chronic kidney disease; ESKD = end stage kidney 
disease 
* ‘Study’ is used here to refer to research conducted with discrete samples; >1 study may be 
reported in one article and >1 article may report on the same study. 
**One evaluation  and one descriptive analysis focused on the same sample.  
***Seven studies included samples from more than one group. 
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Table 3. Measures used in quantitative studies of advance care planning for adults with 
chronic kidney disease 
Measure  Studies 
(N=55) 
Measures 
(N=110) 
  N (%) N % 
      
Knowledge EOL medical interventions 5 (11) 5 (5) 
 ACP 3 (7) 3 (3) 
Preferences Decision maker at EOL 7 (16) 7 (6) 
 EOL medical interventions 12 (27) 12 (11) 
 Information needs 4 (9) 4 (4) 
Attitudes EOL medical interventions  4 (9) 4 (4) 
 Information and promotional material 4 (9) 4 (4) 
 Usefulness of advanced directives 5 (11) 5 (5) 
 Impact on quality of relationships 2 (4) 2 (2) 
 Level of comfort with EOL decision-
making 
7 (16) 7 (6) 
Completion and documentation of advance directives 18 (40) 18 (16) 
Demographic factors predicting preferences, attitudes towards 
advance directives or EOL medical interventions 
14 (31) 14 (13) 
Communication Amount of communication between 
patient, family and physician 
6 (13) 6 (6) 
 Desire to discuss advanced directives 2 (4) 2 (2) 
 Patient–surrogate congruence in end-of-
life care preferences  
6 (13) 6 (6) 
     
EOL care received 8 (18) 8 (7) 
Patient/family well-being or coping 5 (11) 5 (5) 
EOL = end-of-life 
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Table 4. Implementation of recommendations from qualitative research in advance care 
planning interventions for people with chronic kidney disease 
Recommendation from qualitative studies  Interventions addressing the 
recommendations  
Patients should be seen as individuals in world view 
and preferences, and appropriate timing of ACP  
Perry (2005), Song (2009, 2010), 
Weisbord (2003) 60,73,75,92 
Emphasis should be on patients being 
autonomous/taking control and ‘getting things settled’; 
taking care of family (e.g. avoiding burdening them 
with decision-making is a strong motivator) 
Perry (2005), Song (2009, 2010) 
60,73,75 
The medical team should initiate ACP, give 
information and advice (rather than make decisions), 
be empathetic and affirm preferences 
Hopkins (2011), Tigert (2005) 
54,77 
Patients should be helped to acknowledge and accept 
their limited prognosis 
Perry (2005), Song (2009, 2010) 
60,73,75 
Discussion of poor prognosis should be balanced by 
hope  
Perry (2005), Song (2009, 2010) 
60,73,75 
Efforts should be made to improve patient healthcare 
knowledge and literacy 
Song (2009, 2010) 73,75 
Families should be involved in ACP, acknowledging 
that family relationships, viewpoints and perceptions 
of trust have both positive and negative potentials 
Surrogates only 
Patients should be made to feel confident that their 
advance directives will be enacted 
None 
Financial factors should be considered when 
discussing treatments 
None 
Patients should be exposed to others' positive 
experiences and viewpoints on ACP, including its 
social desirability 
Perry (2005) 60 
ACP should be framed as a process of reflection rather 
than a 'cold form' 
Perry (2005), Song (2009, 2010) 
60,73,75 
Decisions about continuing dialysis should not be 
grouped with those regarding aggressive life-
sustaining treatments (e.g. CPR, ventilation); patients 
may perceive these intervention types very differently  
None 
ACP = advance care planning; CPR = cardiopulmonary resuscitation  
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Figure 1. Flowchart of review selection process 
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